The U.S. federal government requires every clinical trial to be reviewed and approved by an Institutional Review Board before enrolling any participants. The IRB evaluates the study design, risk-benefit ratio, and informed consent process. During the study, a Data Safety Monitoring Board (DSMB) independently reviews safety data at regular intervals. The FDA can inspect trial sites and audit data at any time. Informed consent ensures you understand all risks, benefits, alternatives, and your right to withdraw. HIPAA regulations protect your medical information. If an unexpected serious adverse event occurs, it must be reported to the IRB and FDA within strict timelines. These protections work together to prioritize your safety above all else.
Patient Info
How Are Clinical Trial Participants Protected?
Quick Answer
Clinical trial participants are protected by multiple layers of oversight including IRB review, FDA regulations, informed consent requirements, Data Safety Monitoring Boards, and the ethical principles of the Declaration of Helsinki and the Belmont Report.
Take the Next Step
Find clinical trials that match your condition, location, and treatment preferences.